TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases
Authors
Keywords
-
Journal
Open Biology
Volume 10, Issue 9, Pages 200099
Publisher
The Royal Society
Online
2020-09-02
DOI
10.1098/rsob.200099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TAK1 regulates the tumor microenvironment through inflammatory, angiogenetic and apoptotic signaling cascades
- (2020) Scott A. Scarneo et al. Oncotarget
- Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion
- (2018) Scott A. Scarneo et al. Scientific Reports
- TAK1 as the mediator in the protective effect of propofol on renal interstitial fibrosis induced by ischemia/reperfusion injury
- (2017) Huiping Wu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Rheumatoid arthritis: JAK-ing up inadequate RA therapy
- (2017) Sarah Onuora Nature Reviews Rheumatology
- Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
- (2017) Jiefei Geng et al. Nature Communications
- Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
- (2017) Ping Li et al. Frontiers in Pharmacology
- Heterozygous Mutations in MAP3K7 , Encoding TGF-β-Activated Kinase 1, Cause Cardiospondylocarpofacial Syndrome
- (2016) Carine Le Goff et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia
- (2016) Emma M. Wade et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Discovery of a potent and highly selective transforming growth factor β receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD)
- (2016) Terushige Muraoka et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Generation of Janus kinase 1 (JAK1) conditional knockout mice
- (2016) Kazuhito Sakamoto et al. GENESIS
- Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation
- (2016) Douglas S Jones et al. Nature Chemical Biology
- Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K63-Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6
- (2016) Anil K. Singh et al. Arthritis & Rheumatology
- TAK1 selective inhibition: state of the art and future opportunities
- (2015) Iain Kilty et al. Future Medicinal Chemistry
- Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro
- (2015) Wenping Wang et al. INFLAMMATION RESEARCH
- Genetic characteristics of inflammatory bowel disease in a Japanese population
- (2015) Yuta Fuyuno et al. JOURNAL OF GASTROENTEROLOGY
- Cartilage damage in osteoarthritis and rheumatoid arthritis—two unequal siblings
- (2015) Thomas Pap et al. Nature Reviews Rheumatology
- Ethnically shared and heterogeneous impacts of molecular pathways suggested by the genome-wide meta-analysis of rheumatoid arthritis: Table 1
- (2015) Yukinori Okada et al. RHEUMATOLOGY
- The TAK1-NF- B axis as therapeutic target for AML
- (2014) M. C. J. Bosman et al. BLOOD
- Anti-TNF therapy: past, present and future
- (2014) C. Monaco et al. INTERNATIONAL IMMUNOLOGY
- Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)
- (2014) Li Tan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pseudoginsenoside-F11 (PF11) exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1/IKK/NF-κB, MAPKs and Akt signaling pathways
- (2014) Xiaoxiao Wang et al. NEUROPHARMACOLOGY
- TRAF6 Stimulates the Tumor-Promoting Effects of TGF Type I Receptor Through Polyubiquitination and Activation of Presenilin 1
- (2014) S. K. Gudey et al. Science Signaling
- Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies
- (2014) Chong Sun et al. TRENDS IN BIOCHEMICAL SCIENCES
- LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo
- (2014) Jundong Zhou et al. TUMOR BIOLOGY
- Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1
- (2013) Keith R. Hornberger et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: Optimization of kinase selectivity and pharmacokinetics
- (2013) Keith R. Hornberger et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- TAK1 Inhibition in the DFG-Out Conformation
- (2013) Iain Kilty et al. Chemical Biology & Drug Design
- A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
- (2013) Tobias Goldmann et al. NATURE NEUROSCIENCE
- Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol
- (2012) Jiaquan Wu et al. ACS Chemical Biology
- Essential role of TAK1 in regulating mantle cell lymphoma survival
- (2012) D. Buglio et al. BLOOD
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
- (2012) Luke Jostins et al. NATURE
- Targeting of TAK1 in inflammatory disorders and cancer
- (2012) Hiroaki Sakurai TRENDS IN PHARMACOLOGICAL SCIENCES
- Cryptotanshinone inhibits LPS-induced proinflammatory mediators via TLR4 and TAK1 signaling pathway
- (2011) Xin Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- IFN-γ activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 production
- (2010) Michael Conzelmann et al. BIOCHEMICAL PHARMACOLOGY
- TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer
- (2010) Kira Bettermann et al. CANCER CELL
- TGF- -Activated Kinase 1 Signaling Maintains Intestinal Integrity by Preventing Accumulation of Reactive Oxygen Species in the Intestinal Epithelium
- (2010) R. Kajino-Sakamoto et al. JOURNAL OF IMMUNOLOGY
- Pathway Analysis of GWAS Provides New Insights into Genetic Susceptibility to 3 Inflammatory Diseases
- (2009) Hariklia Eleftherohorinou et al. PLoS One
- Epoxyquinol B, a Naturally Occurring Pentaketide Dimer, Inhibits NF-κB Signaling by Crosslinking TAK1
- (2008) Hiroshi KAMIYAMA et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Transforming growth factor-activated kinase 1 induced in spinal astrocytes contributes to mechanical hypersensitivity after nerve injury
- (2008) Hirokazu Katsura et al. GLIA
- TAK1 Regulates Reactive Oxygen Species and Cell Death in Keratinocytes, Which Is Essential for Skin Integrity
- (2008) Emily Omori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice
- (2008) Minghui Tang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
- (2008) Alessandro Sorrentino et al. NATURE CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started